Posted on 20/10/2008 in Pharmaceutical Company Financials Actelion has announced senior members of its management team are set to host a question and answer session on the company's financial results.
The firm explains it will make the details of its fiscal nine-month results available on Tuesday October 21st at 06:00 BST.
After this, an investor conference call will take place between 14:30 BST and 15:45 BST in order for discussion about the results to take place.
The event will also take the form of a webcast.
Actelion is also set to provide an update on its development pipeline, it explains.
UK parties interested in taking part in the conference call should start dialling +44 203 14 74 753 between ten and 15 minutes before the meeting is due to begin.
Meanwhile, those who wish to become involved in the webcast should visit Acetlion's official website prior to the event starting.
The investor webcast will be available for replay through Actelion's website roughly one hour after the call has ended.
In recent weeks, the company announced as of Monday September 22nd, its shares have been trading as part of the Swiss Market Index (SMI), the Swiss blue-chip index.
Jean-Paul Clozel, managing director and chief executive of the company, said: "In just eight years following Actelion's initial listing on the Swiss Stock Exchange, our ability to create growth and subsequent long-term shareholder value has been recognized by today's inclusion of our shares in the SMI."Other news stories from 20/10/2008
Read more in the Zenopa News Archive
How this news is generated
|
